Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
206.56
+0.28 (+0.14%)
Streaming Delayed Price
Updated: 1:20 PM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biogen Idec
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
61
62
Next >
7 Stocks That AI Says Will Make You a Millionaire by 2025
↗
July 13, 2023
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio.
Via
InvestorPlace
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
↗
July 13, 2023
Is the stock a good contrarian buy?
Via
The Motley Fool
P/E Ratio Insights for Biogen
↗
July 12, 2023
Via
Benzinga
Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi
July 10, 2023
Biogen's shares decline after approval of Alzheimer's treatment Leqembi, which modestly slows cognitive decline. Analysts see hurdles to the rollout.
Via
MarketBeat
Biogen Just Reached a Big Milestone. Why Isn't the Stock Rising?
↗
July 09, 2023
Biogen shares are little changed year to date.
Via
The Motley Fool
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today
↗
July 07, 2023
Via
Benzinga
What 29 Analyst Ratings Have To Say About Biogen
↗
July 07, 2023
Via
Benzinga
What's Going On With Biogen Stock Thursday
↗
July 06, 2023
Biogen Inc (NASDAQ: BIIB) shares were flat in Thursday's after-hours session after falling marginally by 0.31% to $284.99 during
Via
Benzinga
How Is The Market Feeling About Biogen?
↗
June 29, 2023
Via
Benzinga
Mixed Jobs Data; Fed Governors Want More Interest Rate Hikes; US, China Spat Rattles Semiconductor Sector: The Week In The Markets
↗
July 07, 2023
Via
Benzinga
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
↗
July 07, 2023
The FDA approved a supplemental marketing application for Biogen Inc (NASDAQ: BIIB)-Eisai Co Ltd (OTC: ESALY) supporting the traditional approval of Leqembi (lecanemab-irmb), making it the first and...
Via
Benzinga
FDA Approves Biogen's Alzheimer's Drug: Here Are Other Companies With Treatments In The Pipeline
↗
July 07, 2023
The FDA fully approved Biogen Inc.’s (NASDAQ: BIIB) Alzheimer’s treatment Leqembi on Thursday, becoming the first Alzheimer’s antibody treatment to reach full approval.
Via
Benzinga
Stock Market Rally Pulls Back As Yields Jump; Tesla, Meta In Focus: Weekly Review
↗
July 07, 2023
Automakers rallied on sales while Meta's Threads had a big launch.
Via
Investor's Business Daily
A Look Into Biogen Inc's Price Over Earnings
↗
June 27, 2023
Via
Benzinga
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
↗
June 21, 2023
Via
Benzinga
FSLR Stock Alert: The $1 Billion Reason First Solar Is Up Today
↗
July 07, 2023
First Solar (FSLR) stock is rising higher on Friday after the solar energy company announced a $1 billion revolving credit facility.
Via
InvestorPlace
Why Is Alibaba (BABA) Stock Up Today?
↗
July 07, 2023
Alibaba (BABA) stock is on the rise Friday as investors react to a few pieces of news considering the Chinese e-commerce giant.
Via
InvestorPlace
BIIB Stock Alert: What to Know as FDA Approves Biogen’s Alzheimer’s Drug
↗
July 07, 2023
Biogen (BIIB) stock is in the news Friday after the pharmaceutical company got approval from the FDA for its Alzheimer's drug.
Via
InvestorPlace
Stock Futures Dip As Traders Eye Friday Jobs Report: Analyst Says Q3 Returns Hinge More On This Catalyst Than Fed Move
↗
July 07, 2023
Via
Benzinga
Top 5 Trending Stocks: Prestige Wealth's IPO, Rivian's Lawsuit, Meta's New Platform, Tesla's Dip, And Biogen's FDA Approval
↗
July 06, 2023
Via
Benzinga
FDA Grants Traditional Approval for LEQEMBI® (lecanemab-irmb) for the Treatment of Alzheimer’s Disease
July 06, 2023
From
Biogen Inc.
Via
GlobeNewswire
3 Biotech Stocks to Make Your ‘Get Rich’ Dreams Come True
↗
July 06, 2023
These high return biotech stocks offer tremendous upside ahead and are likely to soar on the back of several growth drivers
Via
InvestorPlace
Biogen's Make-Or-Break Moment Is Here In Alzheimer's Treatment
↗
July 06, 2023
The FDA is expected to announce Thursday whether it has approved or rejected Biogen's Alzheimer's drug.
Via
Investor's Business Daily
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
↗
July 03, 2023
Biogen Inc (NASDAQ: BIIB) announced new Spinraza (nusinersen) data that were presented at the SMA Research & Clinical Care Meeting
Via
Benzinga
New Data at Cure SMA Highlight Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs After Gene Therapy
June 30, 2023
From
Biogen Inc.
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
June 30, 2023
Via
Benzinga
Amgen Inc. Dividend Stock Analysis
↗
June 30, 2023
The company has paid a cash dividend to shareholders every year since 2011 and has increased its dividend payments for 13 consecutive years.
Via
Talk Markets
Is This a Sign That Biogen's Leqembi Could Obtain FDA Approval Next Month?
↗
June 23, 2023
The catalyst many Biogen investors have been waiting for may soon arrive.
Via
The Motley Fool
Alleged Industrial Espionage Makes an Interesting Story
↗
June 21, 2023
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
Via
The Motley Fool
5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies
↗
June 20, 2023
Via
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
61
62
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
